Purchase Order 75D30123P17444
Award Date
9/14/23
Potential Completion Date
9/30/23
Potential Value
$83K
Federal Agency
CDC Pittsburgh
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $79,796.08 firm-fixed-price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the purchase of a QIAGEN EZ2 Connect MDX system. This equipment will support the CDC's biomedical research, public health, and healthcare programs. Qiagen has provided a range of laboratory products and services to various federal agencies in the past, including the Department of Health...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $60,250.00 firm fixed price purchase order contract to Qiagen, LLC, a division of the parent company Qiagen N.V. The contract has an ultimate completion date of September 28, 2024 and was awarded on September 29, 2023. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academics. This contract does not have a set-aside designation. Qiagen has...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the acquisition of QIAGEN equipment and reagents. The contract, valued at $134,538.38, does not have a set-aside designation. Qiagen N.V. is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research. The company has a history of supporting federal...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $57,348.26 firm fixed-price purchase order contract to Qiagen, LLC, a division of the international provider Qiagen N.V., for QIACUITY equipment and maintenance services. This contract does not have a set-aside designation. Qiagen has a history of providing products and services, such as DNA/RNA extraction kits, next-generation sequencing, and bioinformatics software, to support federal agencies'...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $38,760.96 contract is for laboratory supplies to be delivered by November 1, 2022. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under past...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $205,000 purchase order to Qiagen, LLC for their EZ! ADVANCED XL SYSTEM. Qiagen, a subsidiary of Qiagen N.V., will provide its sample preparation and nucleic acid extraction platform to support CDC programs through a one-month period of performance ending in late August 2023. The firm fixed price contract calls for Qiagen to deliver its proprietary system to help CDC process samples...
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $64,817.75 contract provides planned maintenance services for QIAGEN equipment, with a period of performance through March 31, 2024. Qiagen is a major supplier of molecular diagnostics products and services to federal agencies, including the Department of Health and Human Services, Department of Veterans...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $55,000.00 firm fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. This contract has a completion date of May 21, 2024. Qiagen is a foreign-owned, for-profit manufacturer that has provided a range of products and services to support federal...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the Qiagen N.V. biotechnology company. The $113,138.05 contract is for the provision of QIACUBE HT/QIAXTRACTOR platform equipment, which supports the CDC's biomedical research, public health, and healthcare programs. Qiagen is a well-established federal contractor, holding multiple indefinite delivery vehicles (IDVs) and blanket purchase agreements (BPAs) with...
This federal contract award with ID 75D30124P19812 was issued by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The $219,630.87 firm fixed-price purchase order is for Qiagen's EZ2 CONNECT MDX IVD Extraction System, a sample preparation device used in molecular diagnostics. The contract has a period of performance through November 27, 2024. Qiagen has provided a range of products and services to...